Literature DB >> 23179184

Donepezil induced antecollis in a patient with Parkinson's disease dementia.

Yoon-Sang Oh1, Joong-Seok Kim, Dong Woo Ryu, Kwang-Soo Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23179184     DOI： 10.1007/s10072-012-1242-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  7 in total

1.  Relation between cholinesterase inhibitor and Pisa syndrome.

Authors:  Y T Kwak; I W Han; J Baik; M S Koo
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

2.  Donepezil-induced chorea in Alzheimer's disease.

Authors:  I Nozaki; G Inao; M Yamada
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

3.  Donepezil-induced jaw tremor.

Authors:  In-Uk Song; Joong-Seok Kim; Seon-Young Ryu; Sang-Bong Lee; Jae-Young An; Kwang-Soo Lee
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

4.  Adverse effects associated with the use of donepezil in general practice in England.

Authors:  N R Dunn; G L Pearce; S A Shakir
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

5.  [Case of dementia with Lewy bodies showing cervical dystonia after donepezil administration].

Authors:  Noriko Hasegawa; Ken-Ichi Shimada; Yasuji Yamamoto; Kiyoshi Maeda
Journal:  Rinsho Shinkeigaku       Date:  2010-03

Review 6.  Donepezil: an update.

Authors:  Ben Seltzer
Journal:  Expert Opin Pharmacother       Date:  2007-05       Impact factor: 3.889

7.  Cholinergic-dopaminergic imbalance in Pisa syndrome.

Authors:  Alberto Villarejo; Ana Camacho; Rocío García-Ramos; Teresa Moreno; Marta Penas; Raúl Juntas; Juan Ruiz
Journal:  Clin Neuropharmacol       Date:  2003 May-Jun       Impact factor: 1.592
  7 in total
  2 in total

1.  Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review.

Authors:  Mutsumi Iijima; Mikio Osawa; Shinichiro Uchiyama; Kazuo Kitagawa
Journal:  eNeurologicalSci       Date:  2015-09-16

2.  A Case Report on Dyskinesia Following Rivastigmine Patch 13.3 mg/24 hours for Alzheimer's Disease: Perspective in the Movement Disorders Spectrum Following Use of Cholinesterase Inhibitors.

Authors:  Maria Cristina B Diaz; Raymond L Rosales
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.